Literature DB >> 26393164

The Effect of Fenestration of Lamina Terminalis on the Vasospasm and Shunt-Dependent Hydrocephalus in Patients Following Subarachnoid Haemorrhage.

Masoud Hatefi1, Shirzad Azhary2, Hussein Naebaghaee2, Hasan Reza Mohamadi2, Molouk Jaafarpour3.   

Abstract

BACKGROUND AND AIMS: SAH (Sub Arachnoid Haemorrhage) is a life threatening that is associated with complications such as vasospasm and shunt-dependent hydrocephalus. The purpose of this study was to assess the effect of FLT (Fenestration of Lamina Terminalis) on the incidence of vasospasm and shunt-dependent hydrocephalus in ACoA (Anterior Communicating Artery) aneurismal in SAH.
MATERIALS AND METHODS: The data of 50 ruptured ACoA aneurism patients were selected during the year 2001-2009 admitted to Imam Hussein hospital, Tehran, IR. In a randomized double-blind trial patients assigned in two group {with fenestration (FLT, n=25), without fenestration (No FLT, n=25)}. All patients underwent craniotomy by a single neurosurgeon. Patient's age, sex, Hunt-Hess grade, Fisher grade, vasospasm, presence of hydrocephalus and incidences of shunt-dependent hydrocephalus were compared between groups.
RESULTS: There were no significant differences among groups in relation to demographic characteristics, neurological scale scores (Hunt-Hess grade) and the severity of the SAH (Fisher grade) (p>0.05). The rate of hydrocephalus on admission, were 24% and 16% in FLT and no FLT group respectively (p>0.05). The shunt placement postoperatively in FLT and no FLT group were 16% and 12% respectively (p>0.05). The clinical vasospasm was 20% and 24% in FLT and no FLT group respectively (p>0.05).
CONCLUSION: Despite FLT can be a safe method there were not significant differences of FLT on the incidence of vasospasm and shunt-dependent hydrocephalus. A systematic evaluation with multisurgeon, multicentre and with greater sample size to disclose reality is suggested.

Entities:  

Keywords:  Fenestration; Hydrocephalus; SAH; Vasospasm

Year:  2015        PMID: 26393164      PMCID: PMC4572996          DOI: 10.7860/JCDR/2015/13603.6264

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  24 in total

1.  Complications of decompressive craniectomy for head injury.

Authors:  S Honeybul
Journal:  J Clin Neurosci       Date:  2010-02-23       Impact factor: 1.961

2.  Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited.

Authors:  J Claassen; G L Bernardini; K Kreiter; J Bates; Y E Du; D Copeland; E S Connolly; S A Mayer
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

3.  Does lamina terminalis fenestration reduce the incidence of chronic hydrocephalus after subarachnoid hemorrhage?

Authors:  F Tomasello; D d'Avella; O de Divitiis
Journal:  Neurosurgery       Date:  1999-10       Impact factor: 4.654

Review 4.  Efficacy of lamina terminalis fenestration in reducing shunt-dependent hydrocephalus following aneurysmal subarachnoid hemorrhage: a systematic review. Clinical article.

Authors:  Ricardo J Komotar; David K Hahn; Grace H Kim; Robert M Starke; Matthew C Garrett; Maxwell B Merkow; Marc L Otten; Robert R Sciacca; E Sander Connolly
Journal:  J Neurosurg       Date:  2009-07       Impact factor: 5.115

5.  Microsurgical fenestration of the lamina terminalis reduces the incidence of shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage.

Authors:  Ricardo J Komotar; Alessandro Olivi; Daniele Rigamonti; Rafael J Tamargo
Journal:  Neurosurgery       Date:  2002-12       Impact factor: 4.654

6.  Nonaneurysmal nonperimesencephalic subarachnoid hemorrhage: is it a benign entity?

Authors:  Sunil K Gupta; Rahul Gupta; Virender K Khosla; Sandeep Mohindra; Rajesh Chhabra; Niranjan Khandelwal; Vivek Gupta; Kanchan K Mukherjee; Manoj K Tewari; Ashish Pathak; Suresh N Mathuriya
Journal:  Surg Neurol       Date:  2008-07-09

7.  Risk factors related to hydrocephalus after traumatic subarachnoid hemorrhage.

Authors:  Heng-Li Tian; Tao Xu; Jin Hu; Yu-hui Cui; Hao Chen; Liang-Fu Zhou
Journal:  Surg Neurol       Date:  2007-08-17

8.  Non-aneurysmal non-traumatic subarachnoid hemorrhage: patient characteristics, clinical outcome and prognostic factors based on a single-center experience in 125 patients.

Authors:  Juergen Konczalla; Johannes Platz; Patrick Schuss; Hartmut Vatter; Volker Seifert; Erdem Güresir
Journal:  BMC Neurol       Date:  2014-07-01       Impact factor: 2.474

9.  Comparative efficacy of meloxicam and placebo in vasospasm of patients with subarachnoid hemorrhage.

Authors:  Seyed Mohammad Ghodsi; Niayesh Mohebbi; Soheil Naderi; Mousareza Anbarloie; Ahmad Aoude; Seyed Sohail Habibi Pasdar
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

10.  Influence of lamina terminalis fenestration on the occurrence of the shunt-dependent hydrocephalus in anterior communicating artery aneurysmal subarachnoid hemorrhage.

Authors:  Jae Min Kim; Ji Young Jeon; Jae Hoon Kim; Jin Hwan Cheong; Koang Hum Bak; Choong Hyun Kim; Hyeong Joong Yi; Kwang Myung Kim
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

View more
  3 in total

1.  Association between Hyperglycaemia with Neurological Outcomes Following Severe Head Trauma.

Authors:  Javaher Khajavikhan; Aminolah Vasigh; Taleb Kokhazade; Ali Khani
Journal:  J Clin Diagn Res       Date:  2016-04-01

2.  The effect of fenestration of the lamina terminalis on the incidence of shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage (FISH): Study protocol for a randomized controlled trial.

Authors:  Chuanyuan Tao; Chaofeng Fan; Xin Hu; Junpeng Ma; Lu Ma; Hao Li; Yi Liu; Hong Sun; Min He; Chao You
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 3.  Hydrocephalus after Subarachnoid Hemorrhage: Pathophysiology, Diagnosis, and Treatment.

Authors:  Sheng Chen; Jinqi Luo; Cesar Reis; Anatol Manaenko; Jianmin Zhang
Journal:  Biomed Res Int       Date:  2017-03-08       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.